Successful Use of Cyclooxygenase-2 Inhibitor in a Patient With Aspirin-Induced Asthma

Fred Marks, MD, Piedmont Health Care, Statesville, NC; Kristopher Harrell, PharmD, Rick Fischer, PharmD, Department of Clinical Pharmacy Practice, University of Mississippi Medical Center, Jackson

South Med J. 2001;94(2) 

In This Article

Abstract and Introduction

We describe the case of an aspirin-sensitive asthma patient with a history of anaphylactic reactions to nonsteroidal anti-inflammatory drugs. The patient was subsequently diagnosed with rheumatoid arthritis and treated with a cyclooxygenase (COX)-2 inhibitor without an adverse response. Current prescribing information warns to avoid using COX-2 inhibitors in aspirin-sensitive asthma patients. New evidence suggests that aspirin sensitivity may be linked to the COX-1 pathway, and COX-2 inhibitors, as a result of their selectivity, may be beneficial in patients with aspirin-induced asthma.

Aspirin, or acetylsalicylic acid (ASA), and subsequent nonsteroidal anti-inflammatory drugs (NSAIDs) have been widely used in the treatment of inflammatory processes for many years. Their anti-inflammatory actions are thought to be due to the inhibition of cyclooxygenase (COX) enzymes (COX-1 and COX-2).[1] Since their introduction, in some patients with asthma, ASA and NSAIDs have precipitated a distinct clinical syndrome of bronchospasm, rhinitis, and conjunctivitis known as aspirin-sensitive asthma or aspirin-induced asthma (AIA). Aspirin-sensitive asthma affects as many as 10% of adult asthma patients and is more common in women than in men. However, children are rarely affected; a familial pattern has not been shown.[2,3]

The exact mechanism implicated in AIA is not fully elucidated. Immunologic responses and antigen-antibody mechanisms have been debated[4,5]; however, current theories suggest inhibition of the COX pathway is most likely involved.[6,7] We report the case of a patient with a known history of anaphylactic reaction to aspirin and NSAIDs who was successfully treated with celecoxib without an adverse response.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.